Prognostic factors for the response to treatment in males with genital warts

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 10, 2009, Pages 1156-1160

  Stefanaki, C ^a   Hadjivassiliou, M ^a   Katzouranis, I ^a   Bethimoutis, G ^a   Nicolaidou, E ^a   Anyfantakis, V ^a   Lagogianni, E ^a   Caroni, C ^b   Panagiotopoulos, A ^a   Antoniou, C ^a   Katsambas, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cryotherapy; Genital warts; HPV; Imiquimod; Podophyllinotoxin

Indexed keywords

IMIQUIMOD; PODOPHYLLOTOXIN; VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; DNA DETERMINATION; EDUCATIONAL STATUS; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROGNOSIS; SEXUAL ORIENTATION; TREATMENT RESPONSE; URETHRA; WART VIRUS;

ADOLESCENT; ADULT; AMINOQUINOLINES; ANUS DISEASES; COMBINED MODALITY THERAPY; CONDYLOMATA ACUMINATA; CRYOTHERAPY; GENITAL DISEASES, MALE; HUMANS; MALE; MIDDLE AGED; PODOPHYLLOTOXIN; PROGNOSIS;

EID: 70349104725     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03270.x     Document Type: Article

References (18)

1. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Inf 2006 6 : 21 31.
2. Von Krogh G, Lacey CJN, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Inf 2000 76 : 162 168.
3. Molijn A, Kleter B, Quint W, Van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005 32 (Suppl. 1 S43 S51.
4. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med 2003 127 : 940 945.
5. Maw RD, Kinghorn GR, Bowman CA et al. Imiquimod 55 as an acceptable treatment option for external genital warts in uncircumcised males. J Eur Acad Derm Venereol 2002 16 : 58 62.
6. Garland SM, Sellors JW, Wilksrom A et al. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS 2001 12 : 722 729.
7. Handley JM, Horner T, Maw RD, Lawther H, Dinsmore WW. Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomized observer blind placebo controlled study. Genitourin Med 1991 67 : 297 302.
8. Armstrong DKB, Maw RD, Dinsmore WW et al. A randomized, double-blind, parallel group study to compare subcutaneous interferon alpha 2a plus podophyllin in the treatment of primary condylomata acuminate. Genitourin Med 1994 70 : 389 393.
9. Sherrard J, Riddell L. Comparison of the effectiveness of commonly used clinic-based treatments for external genital warts. Int J STD AIDS 2007 18 : 365 368.
10. Wiley DJ, Douglas J, Beutner K et al. External genital warts: diagnosis, treatment and prevention. Clin Infect Dis 2002 35 (Suppl. 2 S210 S224.
11. Lacey CNJ. Therapy for genital human papillomavirus-related disease. J Clin Virol 2005 32S : S82 S90.
12. Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS 2004 15 : 357 364.
13. Stefanaki C, Katzouranis I, Lagogianni E et al. Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts. Int J STD AIDS 2008 19 : 441 444.
14. Carrasco D, Vander Straten M, Tyring SK. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions. J Am Acad Dermatol 2002 47 : S212 S216.
15. Che YM, Wang JB, Liu YH. Correlation between deoxyribonucleic acid loads of human papillomavirus and recurrence of condylomata acuminata. Int J STD AIDS 2005 16 : 605 607.
16. Goncalves MA, Burattini MN, Donadi EA et al. Risk factors associated with genital warts in HIV-positive Brazilian women. Tumori 2003 89 : 9 15.
17. Habel LA, Van deN, Eeden SK, Sherman KJ et al. Risk factors for incident and recurrent condylomata acuminata among women. A population based study. Sex Transm Dis 1998 25 : 285 292. (Pubitemid 28309065)
18. Opaneye AA. The cellular immune system in female patients with or without genital warts: a study of peripheral white blood cell components. Int J STD AIDS 1999 10 : 815 816.